首页 正文

Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics

{{output}}
Pancreatic ductal adenocarcinoma (PDAC), the predominant subtype of pancreatic cancer, ranks among the deadliest malignancies worldwide, with a 5-year survival rate remaining below 13 %. Its poor prognosis stems from complex anatomical barriers, a dense and he... ...